Medicinal

In this collection of research reported in ACS Axial and Chemical & Engineering News, we explore Ozempic for mental health, alcohol poisoning, nutritious processed food, and other exciting developments.

In this collection of research reported in ACS Axial and C&EN, we feature a new antibiotic, eco-friendly foam packaging, adhesive inspired by slug mucus, and discovery of brain preservation processes.

Learn how SciFinder can help you get the information you need to conduct your own syntheses, analyses, literature searches, and more.

Adjuvants are so important that the Federal Drug Agency evaluates them as part of the vaccine itself. Find out how they protect us from infection.

See how these “super-chemists” are developing inventive ways to defeat cancers, heart disease, and other health conditions.

Find out how MEDI can expose you to new research and connect you to opportunities in medicinal chemistry, even before you graduate.

Stay up to date on Coronavirus news, scientific information, and resources for students.

E-cigarettes deliver lead, arsenic, nickel, and other metals at harmful levels.

Some evidence suggests that growing influenza vaccines inside chicken eggs may make them less effective, but not all experts agree.

Darobactin, which kills E. coli and other deadly pathogens, points the way to a new class of gram-negative antibiotics.

Scientists create an inexpensive sensor based on a 3000-year-old musical instrument.

inChemistry takes a close look at "superchemists" who have paved the way for us all to live healthier, greener lives.

Scientists have engineered yeast with a noscapine pathway, opening up possibilities for many new compounds for cancer-fighting drugs.

FDA okays the therapy Luxturna to restore vision in patients with an inherited form of blindness.

Superpaints. Bendable light. Cure for Hepatitis C. ACS celebrates heroic advancements in health, tech, the environment, and our food supply.

Blood plasma in the world's largest lizard appears to resist deadly infections.

Hallucinogenic drugs that had their heyday in the 1960s gain legitimacy for hard-to-treat psychological conditions.

Doping scandals have led the International Olympic Committee to begin testing athletes for performance enhancing drugs and gene therapy.